Craig H. Lipset MPH

Craig H. Lipset is Head of Clinical Innovation within Global Product Development at Pfizer where his team is responsible for impacting clinical research through digital tools, improving patient engagement, and novel collaborations. He serves on the Board of Directors for the Foundation for Sarcoidosis Research, the Board of Directors for the MedStar Health Research Institute, the Operations Committee for TransCelerate BioPharma, and as a Mentor at health technology accelerator, Blueprint Health. Craig also serves on the Editorial Board for Therapeutic Innovation & Regulatory Science, DIA’s official peer-reviewed scientific journal.

Mr. Lipset previously served as Venture Partner in Pfizer Venture Investments as well as Senior Director in Molecular Medicine within Pfizer research and development. Prior to Pfizer, he served as Associate Vice President of Program Management at Adnexus Therapeutics (acquired by Bristol-Myers Squibb), and on the founding management team for Perceptive Informatics (now part of PAREXEL International).